Effect of lifestyle interventions on glucose regulation among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis

被引:48
作者
Zhang, Xuanping [1 ]
Imperatore, Giuseppina [1 ]
Thomas, William [2 ]
Cheng, Yiling J. [1 ]
Lobelo, Felipe [3 ]
Norris, Keri [4 ]
Devlin, Heather M. [1 ]
Ali, Mohammed K. [3 ]
Gruss, Stephanie [1 ]
Bardenheier, Barbara [1 ]
Cho, Pyone [1 ]
de Quevedo, Isabel Garcia [5 ]
Mudaliar, Uma [3 ]
Saaddine, Jinan [1 ]
Geiss, Linda S. [1 ]
Gregg, Edward W. [1 ]
机构
[1] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
[2] Ctr Dis Control & Prevent, Off Publ Hlth Sci Serv, Atlanta, GA USA
[3] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA
[4] Fulton DeKalb Hosp Author, Hlth Policy & Adm, Atlanta, GA USA
[5] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Off Smoking & Hlth, Atlanta, GA USA
关键词
Lifestyle intervention; Glucose regulation; Systematic review; Meta-analysis; CARDIOMETABOLIC RISK-FACTORS; DIETARY WEIGHT-LOSS; HEALTHY-LIVING PARTNERSHIPS; OBESE POSTMENOPAUSAL WOMEN; RANDOMIZED CLINICAL-TRIAL; HIGH-CARBOHYDRATE DIET; PRIMARY-CARE; PREVENTION PROGRAM; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME;
D O I
10.1016/j.diabres.2016.11.020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study systematically assessed the effectiveness of lifestyle interventions on glycemic indicators among adults (P18 years) without IGT or diabetes. Randomized controlled trials using physical activity (PA), diet (D), or their combined strategies (PA + D) with follow-up P12 months were systematically searched from multiple electronic-databases between inception and May 4, 2016. Outcome measures included fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), fasting insulin (FI), homeostasis model assessment-estimated insulin resistance (HOMA-IR), and bodyweight. Included studies were divided into lowrange (FPG < 5.5 mmol/ L or HbA1c < 5.5%) and high-range (FPG P5.5 mmol/ L or HbA1c P5.5%) groups according to baseline glycemic levels. Seventy-nine studies met inclusion criteria. Random-effect models demonstrated that compared with usual care, lifestyle interventions achieved significant reductions in FPG (-0.14 mmol/ L [ 95% CI, -0.19, -0.10]), HbA1c (-0.06% [-0.09, -0.03]), FI (% change: -15.18% [-20.01, -10.35]), HOMA-IR (% change: - 22.82% [-29.14, -16.51]), and bodyweight (% change: -3.99% [-4.69, -3.29]). The same effect sizes in FPG reduction (0.07) appeared among both low-range and high-range groups. Similar effects were observed among all groups regardless of lengths of follow-up. D and PA + D interventions had larger effects on glucose reduction than PA alone. Lifestyle inter-ventions significantly improved FPG, HbA1c, FI, HOMA-IR, and bodyweight among adults without IGT or diabetes, and might reduce progression of hyperglycemia to type 2 diabetes mellitus.
引用
收藏
页码:149 / 164
页数:16
相关论文
共 128 条
[1]   Translating the Diabetes Prevention Program into the community - The DEPLOY pilot study [J].
Ackermann, Ronald T. ;
Finch, Emily A. ;
Brizendine, Edward ;
Zhou, Honghong ;
Marrero, David G. .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2008, 35 (04) :357-363
[2]   Impact of a nutritional counseling program on prevention of HAART-related metabolic and morphologic abnormalities [J].
Almeida, Luara B. ;
Segurado, Aluisio C. ;
Duran, Ana Clara F. ;
Jaime, Patricia C. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2011, 23 (06) :755-763
[3]   Standards of Medical Care in Diabetes-2014 [J].
不详 .
DIABETES CARE, 2014, 37 :S14-S80
[4]  
Anderssen SA, 1998, SCAND J MED SCI SPOR, V8, P109
[5]   Improved carbohydrate metabolism after physical training and dietary intervention in individuals with the 'atherothrombogenic syndrome'. Oslo Diet and Exercise Study (ODES). A randomized trial [J].
Anderssen, SA ;
Hjermann, I ;
Urdal, P ;
Torjesen, PA ;
Holme, I .
JOURNAL OF INTERNAL MEDICINE, 1996, 240 (04) :203-209
[6]  
[Anonymous], 1993, CONTROL CLIN TRIALS, V14, P229
[7]  
[Anonymous], 1999, Diabetologia, V42, P647
[8]  
[Anonymous], 2014, NAT DIAB STAT REP ES
[9]  
[Anonymous], BMJ
[10]  
[Anonymous], BMJ